spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Prostate Cancer 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 22 Mar 2024
Astellas Receives Positive CHMP Opinion for XTANDI(TM) in Additional Recurrent Early Prostate Cancer Treatment Setting
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 19 Mar 2024
Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 16 Feb 2024
Fusion Pharmaceuticals Enters into Exclusive Worldwide License Agreement with Heidelberg University and Euratom for Actinium-Based PSMA Targeted Radiotherapy
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 25 Jan 2024
Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife(R) System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions
Devices Oncology
 HSMN NewsFeed - 28 Dec 2023
HR Pharmaceuticals, Inc. receives exclusive commercialization rights to Poiesis Medical's Dual Balloon Catheter technology in North America
Devices Licensing
 HSMN NewsFeed - 26 Dec 2023
Amgen Provides Regulatory Update on Status of Lumakras(R) (Sotorasib)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Nov 2023
Vejle Hospital becomes first center in the world to use RayStation for an online adaptive treatment with augmented CBCT
Devices Oncology
 HSMN NewsFeed - 3 Nov 2023
Actinium Appoints Lynn Bodarky as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Sep 2023
Convergent Therapeutics Expands Leadership Team with the Appointments of Neil Bander, MD. as Chief Scientific Officer, Eric M. Sullivan as Chief Financial Officer, and Dimitris Voliotis, MD. as Senior Vice President of Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 May 2023
Convergent Therapeutics Announces $90 Million Series A Financing to Advance the Clinical Development of Radiopharmaceuticals for the Treatment of Prostate Cancer and Other Solid Tumors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 16 Feb 2023
Trial Data Indicates Targeted, Short Course Radiation Therapy Preserves Urinary Continence and Sexual Function Better Than Surgery in Men With Prostate Cancer
Devices Oncology
 HSMN NewsFeed - 27 Dec 2022
Koya Medical Announces the Addition of Chief Medical Officer Dr. Thomas Maldonado to Their Executive Leadership Team
Devices Personnel
 HSMN NewsFeed - 8 Dec 2022
Dantari Debuts with $47 Million Series A to Advance Best-in-Class Targeted Medicines for Solid Tumors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 9 Nov 2022
Ibex Medical Analytics Secures $10M Funding from Kreos Capital
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 25 Oct 2022
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Sep 2022
Dr. Seth Blacksburg Joins Accuray as VP, Chief Medical Officer Americas Region
Devices Oncology Personnel
 HSMN NewsFeed - 25 Aug 2022
Avenda Health Raises $10M in Series B, Innovating Detection and Treatment for Prostate Cancer Care
Devices Oncology Venture Capital
 HSMN NewsFeed - 18 Aug 2022
Jemincare Announces Exclusive License Agreement with Genentech to Develop and Commercialize Novel Oral Androgen Receptor Degrader
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Jul 2022
Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2022
VA Ann Arbor Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
Devices Oncology
 HSMN NewsFeed - 31 May 2022
Sapience Therapeutics Announces $41 Million Series B Financing to Advance Pipeline of Peptide Therapeutics Targeting Protein-Protein Interactions
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 16 May 2022
RadNet Artificial Intelligence Subsidiaries, DeepHealth and Quantib, Obtain FDA Clearance for Mammography and Prostate AI Tools
Devices Radiology FDA
 HSMN NewsFeed - 5 May 2022
Phosplatin Therapeutics Adopts New Corporate Name as Promontory Therapeutics Inc.
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Apr 2022
CellCentric Strengthens Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Feb 2022
TC Biopharm Announces Appointment of New Board Members
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Feb 2022
US FDA "Study May Proceed" Letter for Clarity's Cu-64 SAR-bisPSMA Trial in Prostate Cancer
Biopharmaceuticals Diagnostics Oncology FDA
 HSMN NewsFeed - 8 Dec 2021
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-422 for the Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Dec 2021
Sapience Therapeutics Receives FDA Fast Track Designation for ST101 for the Treatment of Recurrent Glioblastoma Multiforme (GBM)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Dec 2021
Insightec Announces FDA Clearance For Exablate Prostate To Treat Prostate Tissue
Devices Urology FDA
 HSMN NewsFeed - 1 Dec 2021
Curie Therapeutics Raises $75 Million Financing to Further its Mission of Transforming Cancer Care with Precision Radiopharmaceuticals
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Oct 2021
Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Aug 2021
Lightpoint Medical and Telix Pharmaceuticals Announce Strategic Collaboration Agreement
Devices Radiology Oncology
 HSMN NewsFeed - 10 Aug 2021
LQT Therapeutics Announces Closing of US$19M Series A Financing to Advance Lead Compound Through Phase 1 while Advancing Portfolio Assets
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 12 Jul 2021
Cardiff Oncology Announces the Appointments of Katherine L. Ruffner, M.D., as Chief Medical Officer and James E. Levine as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Jun 2021
Lightpoint Medical Expands Executive Leadership Team with Appointment of Graeme Smith to CEO
Devices Personnel
 HSMN NewsFeed - 17 May 2021
INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 May 2021
Astellas' XTANDI(TM) (enzalutamide) Approved by European Commission for Men with Metastatic Hormone-Sensitive Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 25 Mar 2021
Lightpoint Medical Announces $8 Million in Funding to Support Commercial Launch of its Robotic Cancer Detection Probe
Devices Oncology Venture Capital
 HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Nov 2020
With Elekta Studio, Elekta brings complete image-guided brachytherapy workflow to a single room
Devices Oncology Product Launch
 HSMN NewsFeed - 6 Nov 2020
XTANDI(R) (enzalutamide soft capsules) Approved by China NMPA for the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 20 Oct 2020
Ezra Receives FDA Clearance for Prostate Cancer Artificial Intelligence
Devices Radiology Urology FDA
 HSMN NewsFeed - 24 Sep 2020
Leap Therapeutics Announces FDA Fast Track Designation Granted to DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Sep 2020
Phosplatin Therapeutics Announces Two Leadership Appointments
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Aug 2020
Phosplatin Therapeutics Completes $18.4 Million Private Financing Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 24 Aug 2020
Leap Therapeutics Expands Leadership Team with Addition of Two Industry Veterans
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Jun 2020
Cardiff Oncology Secures $13.5 Million Equity Investment from Biotech-Focused Fundamental Institutional Investors Acorn Bioventures and CAM Capital
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 29 May 2020
XTANDI(R) (enzalutamide) Approved by Japan MHLW for the Treatment of Prostate Cancer with Distant Metastasis
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 28 May 2020
Cardiff Oncology Announces Fast Track Designation Granted by the FDA to Onvansertib for Second-Line Treatment of KRAS-Mutated Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 May 2020
Providence Portland Medical Center Begins Patient Treatments with ViewRay's MRIdian Linac
Devices Oncology
 HSMN NewsFeed - 14 May 2020
New Oncotype DX(R) Real-world Evidence Shows for the First Time the Practice-changing Impact of TAILORx Results
Diagnostics Oncology
 HSMN NewsFeed - 20 Apr 2020
Biocept Launches Unique Line of Molecular Assay Kits for Detection of Key Oncogene Mutations Based on its Proprietary Target Selector(TM) Technology Validated for Use in Both Tissue and Blood Samples
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 13 Apr 2020
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2020
NCCN Guidelines Designate Decipher Prostate as "Recommended" for Men with Adverse Pathology after Radical Prostatectomy
Diagnostics Urology Oncology
 HSMN NewsFeed - 25 Feb 2020
First Accuray CyberKnife(R) M6(TM) System Installed in Missouri at Mercy Hospital St. Louis
Devices Oncology
 HSMN NewsFeed - 14 Feb 2020
Biocept Appoints Cory J. Dunn Senior Vice President of Commercial Operations
Diagnostics Oncology Personnel
 HSMN NewsFeed - 13 Feb 2020
Decipher GRID Signature Predicts Benefit from Chemotherapy in Men Diagnosed with Metastatic Prostate Cancer
Diagnostics Oncology
 HSMN NewsFeed - 3 Jan 2020
Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equity Financing
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 16 Dec 2019
Anixa Biosciences Announces Commercial Launch of Cchek(TM) Prostate Cancer Confirmatory Test
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 25 Nov 2019
INHIBITOR Therapeutics Submits Investigational New Drug Application for Treatment of Patients with Late-Stage Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Nov 2019
Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek(TM) Prostate Cancer Study
Diagnostics Urology Oncology
 HSMN NewsFeed - 21 Nov 2019
Biocept Announces the Launch of its Liquid Biopsy Test to Detect TRK Biomarkers in the Blood of Patients Diagnosed with Cancer
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 7 Nov 2019
Biocept Announces CE IVD Marks and Availability of its CEE-Sure(R) Blood Collection Tube and Sample Collection Shipping Kit in Europe
Diagnostics Oncology Regulatory Product Launch
 HSMN NewsFeed - 5 Nov 2019
Regeneron Provides Updates on Phase 3 Libtayo(R) (cemiplimab) Development Program in Advanced Non-small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Oct 2019
Anixa Biosciences Appoints Dr. Thomas Schlumpberger as Executive Vice President of Diagnostics to Head Liquid Biopsy Development and Commercialization Efforts
Diagnostics Oncology Personnel
 HSMN NewsFeed - 10 Sep 2019
Exact Imaging's Transperineal Needle Guide Release Receives CE Mark
Devices Regulatory
 HSMN NewsFeed - 4 Sep 2019
NW Bio Expands Senior Management Team With Dr. Kevin Duffy As Vice President, Medical Affairs & External Collaborations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Aug 2019
Sophiris Bio Announces Completion of $4.0 Million Registered Direct Offering
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Aug 2019
ViewRay Announces Results of the First Prospective Clinical Trial on MR-guided Radiation Treatment for Prostate Cancer Without Implanted Markers
Devices Oncology
 HSMN NewsFeed - 12 Aug 2019
On Target Laboratories Announces Leadership Transition and Appoints Christopher Barys as Chief Executive Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 29 Jul 2019
RenalytixAI Appoints Thomas McLain as President and Chief Commercial Officer
Diagnostics Personnel
 HSMN NewsFeed - 15 Jul 2019
ESSA Expands Leadership Team by appointing Alessandra Cesano as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Jun 2019
Bracco Imaging Expands Portfolio of Personalized Diagnostics With the Acquisition of Blue Earth Diagnostics
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 17 Jun 2019
Pfizer to Acquire Array BioPharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 May 2019
Calidi Biotherapeutics Announces The Appointment Of Seasoned Biotech Executive Dr. Ashok Srivastava To Their Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 May 2019
IO Biotech Initiates Global Phase 2 Portion of Clinical Trial For T-win(R) Immunotherapy in Non-small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Apr 2019
South Africa Hospital Delivers HDR Brachytherapy Cancer Treatments with Varian Bravos Afterloader System
Devices Oncology
 HSMN NewsFeed - 29 Apr 2019
U.S. FDA Accepts New Drug Application and Grants Priority Review for Darolutamide
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Apr 2019
Epic Sciences Receives CE Mark for Liquid Biopsy Test Collection Kit
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 22 Apr 2019
Epic Sciences Appoints Richard J. Wenstrup, M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Apr 2019
Artios Pharma Announces Appointment of Dr. Ian Smith as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Mar 2019
Hoth Therapeutics Enters into Commercial Licensing Agreement with University of Maryland, Baltimore and Isoprene Pharmaceuticals Inc.
Biopharmaceuticals Dermatology Licensing
 HSMN NewsFeed - 22 Feb 2019
Phase 3 Randomized Trial Data Shows SBRT has Similar Acute Safety Profile to Conventional Radiation Therapy in Patients with Localized Prostate Cancer
Devices Oncology
 HSMN NewsFeed - 11 Feb 2019
Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Feb 2019
Sojournix Appoints Ruth Thieroff-Ekerdt, M.D. As Senior Vice President And Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jan 2019
Nanospectra Biosciences Names Michael Brawer, M.D. as Chief Medical Officer
Devices Oncology Urology Personnel
 HSMN NewsFeed - 28 Jan 2019
Biocept Launches Liquid Biopsy Kits Intended to Broaden Use of its Proprietary Technology Platform for High Sensitivity Detection of Circulating Tumor DNA
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 2 Jan 2019
ImaginAb Announces Strengthening of Board and Executive Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Nov 2018
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Nov 2018
HOX Therapeutics Appoints Karl Keegan as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Nov 2018
Arix Bioscience plc: Arix Participates in Harpoon $70m Series C Investment Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 5 Nov 2018
Biocept Announces New Executive Hires to its Sales and Marketing Organization
Diagnostics Oncology Personnel
 HSMN NewsFeed - 25 Oct 2018
Skyline Urology Acquires First ExactVu(TM) Micro-Ultrasound System in California for Real-Time Targeted Prostate Biopsies
Devices Urology
 HSMN NewsFeed - 24 Oct 2018
Anixa Biosciences Announces Scheduling of Pre-Sub Meeting with FDA for its Cchek(TM) Cancer Diagnostic Test
Diagnostics Oncology FDA
 HSMN NewsFeed - 15 Oct 2018
Palette Life Sciences and Nestlé Skin Health Enter into Global Licensing Agreement for Deflux(R), Solesta(R) and Barrigel(TM)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 3 Oct 2018
Trovagene Announces Exclusive License Agreement with MIT for Combination Therapy of Anti-Androgens and Polo-like Kinase Inhibitors in Prostate Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 25 Sep 2018
Largest Prostate SBRT Studies to Date Show Accuray CyberKnife(R) System Provides Excellent Prostate Cancer Survival Rates in Five or Fewer Sessions
Devices Oncology
 HSMN NewsFeed - 19 Sep 2018
OBI Pharma Granted FDA Orphan Drug Designation for OBI-3424 for the Treatment of Acute Lymphoblastic Leukemia (ALL)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Sep 2018
Exact Imaging Announces Health Canada Approval for its FusionVu(TM) Application for Micro-Ultrasound/MRI Fusion
Devices Radiology Regulatory
 HSMN NewsFeed - 10 Sep 2018
Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 5 Sep 2018
Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer
Devices Radiology Oncology Venture Capital
 HSMN NewsFeed - 4 Sep 2018
Epic Sciences Appoints Katherine Atkinson as Chief Commercial Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 4 Sep 2018
Azeria Therapeutics, the World's First Pioneer Factor Drug Discovery Company, Announces Series A Investment from Sixth Element Capital
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 29 Aug 2018
Trovagene Announces European Commission Grants Orphan Drug Designation to Onvansertib (PCM-075) for Treatment of Acute Myeloid Leukemia in Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 27 Aug 2018
Cantex Pharmaceuticals, Inc. Receives FDA Fast Track Designation For CX-01 For The Treatment Of Patients Over Age 60 With Newly Diagnosed Acute Myeloid Leukemia (AML)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Aug 2018
Alpha Tau's High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United States
Devices Oncology Regulatory
 HSMN NewsFeed - 20 Aug 2018
Q BioMed Inc. Announces FDA Filing for Strontium Chloride Sr89 Injection USP for Relief of Metastatic Cancer Bone Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Jul 2018
GenomeDx Announces Medicare Draft Local Coverage Determination (LCD) for Decipher Prostate Biopsy Genomic Classifier
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 9 Jul 2018
OBI Pharma Granted FDA Orphan Drug Designation for OBI-3424 for the Treatment of Hepatocellular Carcinoma (HCC)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Jul 2018
ITUS Corporation Announces Second Commercial Focus for Cchek(TM) will be Breast Cancer
Diagnostics Oncology
 HSMN NewsFeed - 5 Jul 2018
5-Year Outcomes Following A HIFU Focal Therapy Study Demonstrate Impressive Disease Control And Low Side Effect Profile For Prostate Cancer Patients In The U.K.
Devices Oncology
 HSMN NewsFeed - 22 Jun 2018
PharmaEngine Announces Positive Topline Results from Global Pivotal Trial of PEP503 (NBTXR3) in Soft Tissue Sarcoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Jun 2018
Steba Biotech's TOOKAD(R) Vascular Photodynamic Therapy Maintains Significant Reduction in Overall Progression and Conversion to Radical Therapy in Low-risk Prostate Cancer Patients at 4 Years
Biopharmaceuticals Urology Oncology
 HSMN NewsFeed - 19 Jun 2018
GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 8 Jun 2018
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Jun 2018
FDA Expands Lilly's ALIMTA(R) (pemetrexed) Label to Include Combination with KEYTRUDA(R) (pembrolizumab) and Carboplatin as First-Line Treatment for Metastatic Nonsquamous Non-Small Cell Lung Cancer, Irrespective of PD-L1 Expression
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 May 2018
ImaginAb Reconstitutes Scientific Advisory Board
Biopharmaceuticals Oncology Radiology Personnel
 HSMN NewsFeed - 16 May 2018
Roivant Expands Senior Leadership with Key Hires
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 May 2018
Exact Imaging Receives FDA 510(k) Clearance for Adding the FusionVu Application to the ExactVu(TM) Micro-Ultrasound Platform
Devices Urology Oncology FDA
 HSMN NewsFeed - 27 Apr 2018
Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia(R) (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Apr 2018
Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 30 Mar 2018
Epic Sciences and Genomic Health Announce Favorable Draft Local Coverage Determination (LCD) on Medicare Coverage for Use of the Oncotype DX(R) AR-V7 Nucleus Detect(TM) Test in Patients with Metastatic Castration-Resistant Prostate Cancer
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 6 Mar 2018
FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes
Diagnostics Oncology FDA
 HSMN NewsFeed - 1 Mar 2018
Breathtec Biomedical Announces Appointment of CEO
Devices Personnel
 HSMN NewsFeed - 26 Feb 2018
Genomic Health Expands Offering to Prostate Cancer Patients with Launch of Oncotype DX(R) AR-V7 Nucleus Detect(TM) Test to Predict Treatment Response in Metastatic Disease
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 22 Feb 2018
GenomeDx Announces Inclusion of Decipher Genomic Testing in NCCN Guidelines for Prostate Cancer
Diagnostics Oncology
 HSMN NewsFeed - 20 Feb 2018
Merrimack Announces Formation of New Scientific Advisory Board with Extensive Expertise in Precision Oncology
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Feb 2018
ZYTIGA(R) (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Jan 2018
ESSA Announces Management Team Change
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Dec 2017
Progenics Pharmaceuticals Announces FDA Acceptance of New Drug Application for AZEDRA(R) (iobenguane I 131) in Pheochromocytoma and Paraganglioma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Dec 2017
Aytu BioScience Announces Appointment of David Green as Chief Financial Officer
Biopharmaceuticals Urology Personnel
 HSMN NewsFeed - 14 Dec 2017
Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 30 Nov 2017
Epic Sciences Launches Metastatic Breast Cancer Circulating Tumor Cell Panel
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 26 Oct 2017
Aytu BioScience Provides Quarterly Update on the Natesto(R) U.S. Launch
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 11 Oct 2017
Janssen Submits New Drug Application to U.S. FDA for Apalutamide (ARN-509) to Treat Men with Non-Metastatic Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Oct 2017
SutroVax Appoints Veteran Vaccine Experts to Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Oct 2017
Aytu BioScience Announces International Distribution Agreement for Fiera(R) in Japan
Biopharmaceuticals Urology Distribution
 HSMN NewsFeed - 27 Sep 2017
Foresee Pharmaceuticals and TRPharm Announce License and Distribution Agreement
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 25 Sep 2017
IsoRay Announces "Long-term PSA Outcomes in a Single Institution, Prospective Randomized Cesium-131 / Iodine-125 Permanent Prostate Brachytherapy Trial" Poster Presentation at 2017 Annual American Society for Radiation Oncology (ASTRO) Conference
Devices Oncology
 HSMN NewsFeed - 20 Sep 2017
Trovagene Strengthens Board of Directors with Appointment of Oncology Development Veteran Dr. Athena Countouriotis
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Sep 2017
Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Sep 2017
Hereditary Cancer Risk Assessment Is an Important Option for Prostate Cancer Patients during Prostate Cancer Awareness Month
Diagnostics Oncology
 HSMN NewsFeed - 6 Sep 2017
Oxeia Biopharmaceuticals, Inc. Announces Appointment Of Dr. Michael Wyand As Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 5 Sep 2017
Biocept Launches Liquid Biopsy Test for NRAS Mutations
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 14 Aug 2017
Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR
Diagnostics Oncology Distribution
 HSMN NewsFeed - 10 Aug 2017
Biocept Announces Private Placement of $2.2 Million of Common Stock with Ally Bridge LB Healthcare Master Fund
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 20 Jul 2017
Churchill Pharmaceuticals Announces NDA Filing Acceptance for YONSA(TM) by the U.S. FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Jul 2017
Biocept Expands Commercial Offering of Clinically Actionable Biomarker Assays with Launch of Liquid Biopsy Test for Progesterone Receptor Detection
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 13 Jul 2017
American Society for Radiation Oncology Updates Insurance Coverage Recommendations for Proton Therapy
Devices Oncology
 HSMN NewsFeed - 13 Jul 2017
Aytu BioScience Expands MiOXSYS(R) Distribution Network with a Fertility-Focused Company in Over 20 Countries in Europe
Diagnostics Urology Distribution
 HSMN NewsFeed - 30 May 2017
Churchill Pharmaceuticals Expands Commercial Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 May 2017
Medicare Coverage of Prolaris(R) Test Expands with the Addition of Men Diagnosed with Favorable Intermediate Risk Prostate Cancer
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 11 May 2017
New Data Reinforce Benefits of TomoTherapy(R) Platform for Mainstream Radiation Therapy Treatment Indications
Devices Oncology
 HSMN NewsFeed - 5 May 2017
Ram Group Next Generation Sensor Platform Will Bring Point-of-Care Diagnostics and Wearables to Emerging Markets to Address Global Health Issues
Diagnostics Monitoring
 HSMN NewsFeed - 2 May 2017
ViewRay Showcases World's First Commercially Available MRI-Guided Linac System at Leading European Radiation Oncology Meeting
Devices Oncology Product Launch
 HSMN NewsFeed - 28 Apr 2017
Epic Sciences Announces Completion of $40 Million Series D Financing
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 26 Apr 2017
Urology of Virginia First US Practice to Acquire Novel ExactVu(TM) Micro-Ultrasound System for Prostate Imaging and Biopsy
Devices Urology Oncology
 HSMN NewsFeed - 19 Apr 2017
Advaxis Appoints Anthony Lombardo as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Apr 2017
Roche Launches Antibody Test to Aid in Diagnosis of Challenging Prostate Cancer Cases
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 10 Apr 2017
Axovant Sciences Announces Appointment of Dr. David Hung as Chief Executive Officer and Expansion of Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 5 Apr 2017
Foresee Pharmaceuticals Announces Completion of USD16M Fundraising
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 29 Mar 2017
Tyme Technologies Announces Two New Board of Director Appointments -- David Carberry and James Biehl
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Mar 2017
Tyme Appoints Ben Taylor as President and Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Mar 2017
Exact Imaging Introduces New FusionVu(TM) micro-US/MRI Fusion to Complement its ExactVu(TM) Micro-Ultrasound System for Prostate Imaging and Biopsy
Devices Urology Product Launch
 HSMN NewsFeed - 9 Mar 2017
Exact Imaging Announces Health Canada Approval and License for its ExactVu(TM) micro-ultrasound system for prostate imaging and biopsy
Devices Urology Regulatory
 HSMN NewsFeed - 17 Feb 2017
LYNPARZA(TM) (olaparib) Meets Primary Endpoint in Phase III Trial in BRCA-Mutated Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Feb 2017
First U.S. Multi-center Investigational Clinical Trial of 177 Lu PSMA-617 Targeted Radioligand Therapy in Metastatic Castration Resistant Prostate Cancer Receives FDA Clearance
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Feb 2017
Bovie Medical Provides J-Plasma(R) Update
Devices Surgery Distribution
 HSMN NewsFeed - 27 Jan 2017
Foresee Pharmaceuticals Announces Top-Line Results from Phase 3 Registration Study in Advanced Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Jan 2017
Myovant Sciences Initiates Phase 3 Clinical Program of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Biopharmaceuticals
 HSMN NewsFeed - 9 Jan 2017
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 23 Dec 2016
Progenics Pharmaceuticals Announces Independent Committee’s Positive Recommendation for Continuation of Phase 3 Clinical Trial of SPECT/CT Imaging Agent 1404
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Dec 2016
Genomic Health Announces Results from Multiple Oncotype DX(R) Studies, Reinforcing its Impact in Delivering Precision Medicine to Breast Cancer Patients Around the World
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 23 Nov 2016
Exact Imaging Receives CE Mark Approval for its ExactVu(TM) Micro-Ultrasound System for Prostate Imaging and Biopsy
Devices Oncology Urology Regulatory
 HSMN NewsFeed - 16 Nov 2016
Myovant Sciences Appoints Terrie Curran to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Sep 2016
Threshold Pharmaceuticals Announces Interim Results from Tarloxotinib Program and its Plans to Focus on Evofosfamide and Earlier-Stage Opportunities
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Sep 2016
Pfizer Completes Acquisition of Medivation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Sep 2016
Prospective, Multi-Institutional Study Shows Five Treatments with the CyberKnife(R) System Provide Excellent Disease Control for Prostate Cancer Patients
Devices Oncology
 HSMN NewsFeed - 22 Aug 2016
Pfizer to Acquire Medivation
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 28 Jul 2016
Journal of Urology Publishes Results of Exact Imaging's Initial PRI-MUS(TM) Protocol using High Resolution Micro-Ultrasound
Devices Urology Oncology
 HSMN NewsFeed - 26 Jul 2016
Janssen Announces Clinical Collaboration with Bristol-Myers Squibb to Evaluate Immuno-oncology Combination in Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Jul 2016
Advaxis Appoints Ranya Dajani as Vice President, Corporate Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Jul 2016
David Meek appointed as Chief Executive Officer of Ipsen
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2016
OPKO Health to Acquire Transition Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Jun 2016
Merck Receives CHMP Positive Opinion for KEYTRUDA(R) (pembrolizumab) for the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 21 Jun 2016
Keryx Biopharmaceuticals Appoints Two New Board Members
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2016
Bradley Campbell, President and COO of Amicus Therapeutics, elected to Progenics Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Jun 2016
Bayer and Orion Expand Clinical Development Program for BAY-1841788 (ODM-201) in Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2016
Oncternal Therapeutics Merges with Tokalas to Form Clinical-Stage Biotechnology Company with Promising Oncology Pipeline
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 19 May 2016
Decipher Prostate Cancer Test Guides Timing of Postoperative Radiotherapy
Diagnostics Devices Oncology
 HSMN NewsFeed - 11 Apr 2016
Profound Medical Corp., receives CE Mark Approval for TULSA-PRO(TM)
Devices Urology Regulatory
 HSMN NewsFeed - 6 Apr 2016
Janssen Enters Worldwide Collaboration and License Agreement with TESARO, Inc., for Niraparib in Prostate Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 24 Mar 2016
Pivotal Phase III Trial of enzalutamide Initiated in Metastatic Hormone Sensitive Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Mar 2016
Tokai Strengthens Development Team Through the Addition of Kelly Lindert, M.D., as Executive Vice President and Head of Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Mar 2016
Eigen USA and Hitachi Medical Systems Europe Switzerland Announce a Collaborative Agreement for Hitachi to Distribute the Artemis, Eigen's Robotic 3D Targeted Prostate Biopsy Device
Devices Oncology Distribution
 HSMN NewsFeed - 10 Mar 2016
ProMark(R) Prostate Cancer Prognostic Now Included in NCCN Guidelines
Diagnostics Oncology
 HSMN NewsFeed - 1 Mar 2016
Endocare Announces Signing Of Exclusive Agreement With R-Action Distribution
Devices Oncology Distribution
 HSMN NewsFeed - 22 Feb 2016
Amgen And UCB Announce Positive Top-Line Results From The Phase 3 Study Of Romosozumab In Postmenopausal Women With Osteoporosis
Biopharmaceuticals
 HSMN NewsFeed - 19 Feb 2016
Novogen Patent Covering Cantrixil and Trilexium has Proceeded to Grant
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Feb 2016
Aytu BioScience Announces First Commercial Sales for Company's MiOXSYS(TM) System for Male Infertility
Devices Urology Product Launch
 HSMN NewsFeed - 9 Feb 2016
UroGen Pharma Strengthens Board of Directors and Senior Management Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Feb 2016
GenomeDx Publishes First Study Supporting Use of Decipher Test in Prostate Biopsy
Diagnostics Oncology
 HSMN NewsFeed - 27 Jan 2016
Aytu BioScience Announces Additions to Board of Directors
Biopharmaceuticals Urology Personnel
 HSMN NewsFeed - 25 Jan 2016
Steba Biotech Completes its European Phase 3 Clinical Trial of TOOKAD(R) in Patients with Low-Risk Prostate Cancer and Submits Marketing Authorization Application to the European Medicine Agency
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 12 Jan 2016
Aytu BioScience Obtains CE Marking for Company's MiOXSYS(TM) System for Male Infertility
Biopharmaceuticals Urology Regulatory
 HSMN NewsFeed - 8 Jan 2016
MDNA Life Sciences Appoints New Management Team Members to Lead Development and Commercialization of Mitochondrial Diagnostic Pipeline
Diagnostics Oncology Personnel
 HSMN NewsFeed - 24 Dec 2015
Eagle Pharmaceuticals Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Dec 2015
EDAP Receives Russian Regulatory Approval for Focal One(R) HIFU Device
Devices Oncology Urology Regulatory
 HSMN NewsFeed - 17 Nov 2015
Profound Medical Corp. Announces Departure of CFO
Devices Oncology Urology Personnel
 HSMN NewsFeed - 3 Nov 2015
CureVac raises $110 Million in a private placement
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Nov 2015
New CyberKnife(R) and TomoTherapy(R) System Data Presented at Leading Scientific Industry Meeting
Devices Oncology
 HSMN NewsFeed - 20 Oct 2015
Wilson Therapeutics Appoints Andrew Kay as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2015
Teikoku Pharma USA and Eagle Pharmaceuticals Enter into License Agreement for Docetaxel, Non-Alcohol Formula
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 15 Oct 2015
GenomeDx Biosciences Adds Tina Nova and Craig Johnson to Board of Directors
Diagnostics Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 13 Oct 2015
GTx Receives FDA Clearance to Initiate Clinical Trial in Stress Urinary Incontinence
Biopharmaceuticals Urology FDA
 HSMN NewsFeed - 12 Oct 2015
Uptake Medical Announces First-in-Human Lung Cancer Tumor Ablation Using Intervapor(R) Targeted Vapor Therapy
Devices Oncology
 HSMN NewsFeed - 12 Oct 2015
Teva Announces Exclusive Launch of Generic Avodart(R) Capsules in the United States
Biopharmaceuticals Urology Generics Product Launch
 HSMN NewsFeed - 5 Oct 2015
Precision Biopsy Raises $33.6 Million to Accelerate the Commercial Expansion of its ClariCore(TM) Biopsy System
Devices Urology Venture Capital
 HSMN NewsFeed - 16 Sep 2015
Tokai Pharmaceuticals Augments Commercialization Capabilities through Appointment of Lisa Taylor as Senior Vice President, Commercial Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Sep 2015
Metamark Genetics Appoints Kenneth E. Weg as President and Chief Executive Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 2 Sep 2015
Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 25 Aug 2015
EDAP Provides Formal Response to FDA Addressing All Concerns Raised in July 2015 Ablatherm HIFU Letter
Devices Oncology FDA
 HSMN NewsFeed - 17 Aug 2015
GE Healthcare First to Receive FDA Clearance for Low Dose CT Lung Cancer Screening
Devices Oncology Radiology FDA
 HSMN NewsFeed - 30 Jul 2015
Theragenics to Distribute the AccuBoost(R) Technology for Treatment of Early Stage Breast Cancer
Devices Oncology Distribution
 HSMN NewsFeed - 30 Jul 2015
Japanese Approval Trial for Stress Urinary Incontinence Using Cytori Cell Therapy Announced
Regenerative Medicine Urology Oncology Regulatory
 HSMN NewsFeed - 21 Jul 2015
Philips and Profound Medical Collaborate to Advance Treatment for Prostate Cancer Patients
Devices Oncology Urology
 HSMN NewsFeed - 14 Jul 2015
EDAP Names Francois Dietsch Chief Financial Officer
Devices Oncology Personnel
 HSMN NewsFeed - 14 Jul 2015
New CyberKnife(R) System Data Presented at Leading Scientific Industry Meeting
Devices Oncology
 HSMN NewsFeed - 8 Jul 2015
GTx Appoints Diane Young, M.D. as Vice President, Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 May 2015
Myriad Presents New myRisk(TM) Hereditary Cancer Data at 2015 ASCO Annual Meeting
Diagnostics Oncology
 HSMN NewsFeed - 6 May 2015
EMD Serono Initiates Co-Promotion of XALKORI(R) (crizotinib) with Pfizer in the United States
Biopharmaceuticals Oncology Distribution
 HSMN NewsFeed - 2 Apr 2015
Augmenix Announces FDA Clearance of SpaceOAR(R) System
Devices Oncology FDA
 HSMN NewsFeed - 19 Mar 2015
Janssen Acquires XO1 Limited
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Mar 2015
Bristol-Myers Squibb Signs Exclusive Agreement with Bavarian Nordic for PROSTVAC(R), a Prostate-Specific Antigen-Targeting Cancer Immunotherapy
Biopharmaceuticals Licensing Oncology
 HSMN NewsFeed - 2 Mar 2015
Boston Scientific Announces Definitive Agreement To Acquire American Medical Systems' Urology Portfolio For Up To $1.65 Billion
Devices Urology Mergers & Acquisitions
 HSMN NewsFeed - 26 Feb 2015
EDAP Expands Product Portfolio With New Urological Stone Lasers
Devices Urology
 HSMN NewsFeed - 9 Feb 2015
Texas Center For Proton Therapy Names Dr. Andrew K. Lee Medical Director
Devices Oncology Personnel
 HSMN NewsFeed - 3 Feb 2015
U.S. FDA Grants Priority Review for YONDELIS(R) (trabectedin) for the Treatment of Patients with Advanced Soft Tissue Sarcoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Dec 2014
Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology
Biopharmaceuticlas Oncology Personnel
 HSMN NewsFeed - 2 Dec 2014
Study Shows Prolaris(R) Could Save Healthcare System $6 Billion Over 10 Years
Diagnostics Urology Oncology
 HSMN NewsFeed - 21 Oct 2014
Viamet Announces $60 Million Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Sep 2014
Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Sep 2014
BIND Therapeutics Appoints Two New Board Members
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Aug 2014
Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Aug 2014
Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Aug 2014
OncoGenex Pharmaceuticals Announces Appointment of John A. Bencich as Vice President and Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Aug 2014
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery
Devices Neurosurgery Oncology
 HSMN NewsFeed - 5 Aug 2014
EDAP Comments on FDA Panel Vote
Devices Oncology FDA
 HSMN NewsFeed - 29 Jul 2014
Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer
Biopharmaceuticals Diagnostics Oncology Licensing
 HSMN NewsFeed - 9 Jul 2014
CIMTEC announces spin-off company Focal Healthcare, Inc. to develop the new "gold standard" of targeted prostate biopsy and therapy devices for the management of prostate cancer
Devices Oncology Urology
 HSMN NewsFeed - 20 Jun 2014
IsoRay Announces New Russian and Peruvian International Distributor Agreements for the Sale of IsoRay's Full Line of Products
Devices Oncology Distribution
 HSMN NewsFeed - 19 Jun 2014
Takeda Announces Termination of Orteronel (TAK-700) Development for Prostate Cancer in Japan, U.S.A. and Europe
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Jun 2014
Navidea Biopharmaceuticals’ Lymphoseek(R) (technetium Tc 99m tilmanocept) Injection Demonstrates Preferential Accumulation in Tumor-Positive Sentinel Lymph Nodes in Post-Hoc Analysis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2014
Orion and Bayer enter global agreement for development and commercialization of novel prostate cancer treatment - Orion upgrades full-year outlook for 2014
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 May 2014
Guardant Health Announces US Commercial Launch of Guardant360(TM): A Breakthrough Blood Test for Real-Time Cancer Patient Treatment Management
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 29 May 2014
Aduro Announces License Agreement with Johnson & Johnson Innovation for Novel Immunotherapies for Prostate Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 27 May 2014
Orient EuroPharma and Debiopharm Group(TM) Announce Their Partnership and the Launch of Pamorelin(R) LA in Singapore
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 May 2014
IsoRay's Liquid Cesium-131 (Cesitrex(R)) Recieves Final Regulatory Approval for Use in GliaSite(R) Brain Cancer Treatment System
Devices Oncology Regulatory
 HSMN NewsFeed - 21 Apr 2014
EDAP Announces Reimbursement of HIFU Treatment for Prostate Cancer by France's Ministry of Health
Devices Oncology Reimbursement
 HSMN NewsFeed - 7 Apr 2014
Merck Serono Announces Initiation of Phase III START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Apr 2014
GTx Announces Departure of CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Apr 2014
Astellas Announces European Regulatory Submission For XTANDI(R) (enzalutamide) Capsules For Chemotherapy-Naive Metastatic Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 2 Apr 2014
Leading Cancer Center in Italy Introduces Wider Range of Non-Surgical Cancer Treatments Using Varian's Edge(TM) Radiosurgery System
Devices Oncology
 HSMN NewsFeed - 19 Mar 2014
IsoRay Announces World's First Pediatric Cesium-131 Seeded Mesh Treatment for Metastatic Wilms Tumor
Devices Oncology
 HSMN NewsFeed - 6 Mar 2014
U.S. FDA Approves AVEED(TM) (Testosterone Undecanoate) Injectable Testosterone Replacement Therapy For Men Living With Hypogonadism, Or Low-T
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Mar 2014
Leading Cancer Center in Portugal Becomes First in World to Offer Edge(TM) Radiosurgery
Devices Oncology
 HSMN NewsFeed - 3 Mar 2014
Myriad Publishes Clinical Utility Study for Prolaris(R)
Diagnostics Urology
 HSMN NewsFeed - 27 Feb 2014
Arno Therapeutics Appoints Lawrence A. Kenyon Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Feb 2014
iCAD Appoints Dr. Robert Goodman to Board of Directors
Devices Radiology Oncology Personnel
 HSMN NewsFeed - 19 Feb 2014
Lilly Announces Ramucirumab Phase III Lung Cancer Trial Meets Primary Endpoint of Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Feb 2014
Tokai Pharmaceuticals Appoints John McBride as Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Feb 2014
Ipsen announces positive top line results from phase III clinical study of Decapeptyl(R) (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with prostate cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Jan 2014
IsoRay Receives Five Year CE Mark Extension for All Cesium-131 Seed Products
Devices Oncology Regulatory
 HSMN NewsFeed - 29 Jan 2014
Genomic Health Announces Results of Oncotype DX(R) Colon Cancer Studies Presented at 2014 American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI) Symposium
Diagnostics Oncology
 HSMN NewsFeed - 29 Jan 2014
Myriad's Prolaris(R) Test Significantly Modifies Treatment Decisions for Patients With Prostate Cancer
Diagnostics Oncology
 HSMN NewsFeed - 22 Jan 2014
Janssen Announces New Group Targeting Unmet Global Health Needs
Biopharmaceuticals
 HSMN NewsFeed - 7 Jan 2014
BIND Therapeutics Announces Departure of Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Jan 2014
FDA Clears IsoRay's Liquid Cesium (Cesitrex)(TM) for Use With GliaSite(R) in Treating Glioblastomas and Metastatic Brain Cancers
Devices Oncology FDA
 HSMN NewsFeed - 7 Jan 2014
Bellicum Pharmaceuticals Raises $34.4 Million in a Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 7 Jan 2014
Navidea Biopharmaceuticals Expands Lymphoseek(R) Global Commercialization Efforts
Biopharmaceuticals Radiology Distribution
 HSMN NewsFeed - 3 Jan 2014
Metabolon Closes $15 Million Series E Financing
Diagnostics Venture Capital Personnel
 HSMN NewsFeed - 26 Dec 2013
German Clinic's New Elekta Versa HD System Boosts Radiotherapy Speed and Precision in First Patient Treatments
Devices Oncology
 HSMN NewsFeed - 19 Dec 2013
University of California San Diego and John Muir Medical Center Initiate Treating Patients for Colon and Lung Cancer Utilizing IsoRay's Cesium-131 Seeded Mesh
Devices Oncology
 HSMN NewsFeed - 19 Dec 2013
Study Shows Robotic-Assisted Prostate Surgery Reduces Hospital Readmission and Complication Rates Compared to Open Surgery
Devices Surgery Oncology
 HSMN NewsFeed - 10 Dec 2013
FDA Grants Fast Track Designation to Navidea Biopharmaceuticals’ Lymphoseek(R) for Sentinel Lymph Node Detection in Patients with Head and Neck Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 4 Dec 2013
Myriad's Prolaris(R) Test Guides Treatment Decisions for Men with Prostate Cancer
Diagnostics Urology Oncology
 HSMN NewsFeed - 29 Nov 2013
New Data Show Efficacy, Safety and Tolerability of Xeplion(R) in Patients with Schizophrenia at Various Stages of the Disease
Biopharmaceuticals
 HSMN NewsFeed - 31 Oct 2013
Stem Cell Therapeutics Receives U.S. Orphan Drug Designation for the Use of Tigecycline to Treat Acute Myeloid Leukemia
Regenerative Medicine Oncology FDA
 HSMN NewsFeed - 11 Oct 2013
Auxilium Pharmaceuticals, Inc. Announces License Agreement For The Marketing Rights To STENDRA(TM) In The United States And Canada
Biopharmaceuticals Licensing
 HSMN NewsFeed - 3 Oct 2013
Soligenix Appoints Oreola Donini, PhD, as Vice President of Preclinical Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2013
Genomic Health Announces Presentation of Oncotype DX(R) Studies Reinforcing Value of Tests in Guiding Treatment for Multiple Cancers
Diagnostics Oncology
 HSMN NewsFeed - 17 Sep 2013
Dendreon Announces Marketing Authorization for PROVENGE(R) in the European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Sep 2013
Metamark Announces Positive Results of ProMark(TM) Prostate Cancer Clinical Validation Study
Diagnostics Oncology
 HSMN NewsFeed - 26 Aug 2013
GeneDx Introduces Advanced Genetic Test Panels for Inherited Cancer Including Breast and Colon Cancer
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 28 Jun 2013
Dendreon Receives Positive Opinion for PROVENGE(R) in the European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 26 Jun 2013
VIVUS Announces SPEDRA (avanafil) Approval in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Jun 2013
IsoRay Announces a New International Distributor in Australia and New Zealand
Devices Oncology Distribution
 HSMN NewsFeed - 24 Jun 2013
XTANDI(TM) (Enzalutamide) Authorized in the European Union for Advanced Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Jun 2013
Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Jun 2013
Veran Medical Technologies Launches SPiNDrive(R) 2.0, as American College of Chest Physicians Recognizes This Technology in New Guidelines
Devices Oncology Product Launch
 HSMN NewsFeed - 5 Jun 2013
Astellas Signs Distribution Agreement With Tecnofarma For Enzalutamide In Latin America
Biopharmaceuticals Distribution
 HSMN NewsFeed - 4 Jun 2013
First Head-to-Head Study Shows Greenlight XPS(R) Laser Therapy Equally Safe and Effective with Faster Recovery as Commonly Used Turp for Treatment of BPH
Devices Urology
 HSMN NewsFeed - 27 May 2013
Leeds’ St James’s Institute of Oncology Acquires Two Elekta Versa HD Radiotherapy Systems
Devices Oncology
 HSMN NewsFeed - 24 May 2013
Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 May 2013
Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients
Devices Oncology
 HSMN NewsFeed - 16 May 2013
NW Bio Initiates Phase III DCVax(R)-L Brain Cancer Trial In Europe: King's College Hospital In The UK Is First Site To Open
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 May 2013
Tokai Pharmaceuticals Announces $35.5 Million Series E Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 7 May 2013
ASTRO and AUA Issue Joint Guideline for Radiation Therapy After Prostatectomy
Devices Urology Oncology
 HSMN NewsFeed - 3 May 2013
iCAD’s Xoft Intraoperative Radiation Therapy System Featured at American Society of Breast Surgeons Conference
Devices Surgery Oncology
 HSMN NewsFeed - 2 May 2013
SonaCare Medical to Launch FDA-Cleared Sonatherm(R) HIFU Surgical Ablation System at American Urology Association (AUA) Annual Meeting
Devices Oncology Urology Product Launch
 HSMN NewsFeed - 2 May 2013
A.P. Pharma Appoints New Management Team
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 29 Apr 2013
ProUroCare Announces Changes to Management and Board of Directors
Devices Urology Personnel
 HSMN NewsFeed - 16 Apr 2013
Prostate Cancer Patient Receives First Treatment Using Latest Version of Vitesse Real-Time Brachytherapy Planning System from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 10 Apr 2013
Theragenics Launches Torx(TM) Transitionless Guidewires
Devices Interventional Product Launch
 HSMN NewsFeed - 10 Apr 2013
U.K. Clinic Anticipating New Era of Radiotherapy Speed and Precision with Elekta’s New Versa HD System
Devices Oncology
 HSMN NewsFeed - 28 Mar 2013
Varian Medical Systems Appoints Deepak "Dee" Khuntia M.D. Vice President of Medical Affairs
Devices Oncology Personnel
 HSMN NewsFeed - 27 Mar 2013
Elekta’s Advanced Versa HD System to Begin Treating Cancer Patients at New Swiss Radiotherapy Clinic
Devices Oncology
 HSMN NewsFeed - 14 Mar 2013
EDAP Introduces Focal.One(R): A New Robotic HIFU Device for Focal Therapy of Prostate Cancer
Devices Oncology Product Launch
 HSMN NewsFeed - 5 Mar 2013
Myriad's Prolaris(R) Test Predicts Risk of Prostate Cancer Recurrence in Fourth Peer Reviewed Study
Diagnostics Urology Oncology
 HSMN NewsFeed - 4 Mar 2013
The Radiosurgery Society(TM) Completes the 2013 Scientific Meeting Focused on Bridging the Gap: Working Together
Devices Oncology
 HSMN NewsFeed - 22 Feb 2013
EDAP's Ablatherm-HIFU Offers Reliable Therapy for Localized Prostate Cancer
Devices Urology Oncology
 HSMN NewsFeed - 13 Feb 2013
Prostate Cancer Patients Treated with Proton Therapy at Loma Linda University Medical Center Show Excellent Quality of Life
Devices Oncology
 HSMN NewsFeed - 8 Feb 2013
EDAP's Ablatherm-HIFU Demonstrates Long-Term Efficacy and Safety Over Fourteen-Year Period
Devices Oncology
 HSMN NewsFeed - 1 Feb 2013
EDAP Submits U.S. FDA Pre-Market Approval Application for Ablatherm(R)-HIFU for Treatment of Low Risk, Localized Prostate Cancer
Devices Oncology FDA
 HSMN NewsFeed - 31 Jan 2013
Aduro Announces $6.5 Million Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 28 Jan 2013
New NCCN Guidelines for Patients(R) Available for Adolescents and Young Adults with Cancer
Biopharmaceuticals Devices Oncology
 HSMN NewsFeed - 28 Jan 2013
Augmenix Receives FDA Clearance to Market Its TraceIT(TM) Tissue Marker
Devices Oncology Radiology FDA
 HSMN NewsFeed - 28 Jan 2013
Results from Active Biotech's Phase II/III ANYARA trial for the treatment of renal cell cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Jan 2013
Varian Medical Systems Receives FDA 510(k) Clearance for Vitesse(TM) Brachytherapy Treatment Planning Software
Devices Oncology FDA
 HSMN NewsFeed - 23 Jan 2013
Strand Diagnostics appoints new President
Diagnostics Personnel
 HSMN NewsFeed - 22 Jan 2013
Clinical Trials Advancing Proton Therapy Research Open at the CDH Proton Center, A ProCure Center
Devices Oncology
 HSMN NewsFeed - 7 Jan 2013
Celator(R) Pharmaceuticals Announces Appointment of Lisa DeLuca as Vice President, Regulatory Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Jan 2013
Predictive Biosciences Appoints Diagnostics Industry Veteran Pierre Cassigneul as Chief Executive Officer
Diagnostics Oncology Urology Personnel
 HSMN NewsFeed - 17 Dec 2012
Elekta: New Clarity Soft Tissue Visualization Software Neutralizes Organ Motion Challenges During Prostate Cancer Radiotherapy
Devices Oncology FDA
 HSMN NewsFeed - 11 Dec 2012
IsoRay's Cesium-131 Seeds Proves Successful for Brain Cancer Treatment as Presented by Weill Cornell and Barrow Neurological to The Society Of Neuro-Oncology
Devices Oncology
 HSMN NewsFeed - 7 Dec 2012
Dr. Reddy's Launches Debiopharm's Pamorelin(R) LA in India for the Treatment of Locally Advanced or Metastatic, Hormone-Dependent Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Nov 2012
ZYTIGA(R) Receives Positive Regulatory Recommendation in the European Union for Treatment of Metastatic Castration-Resistant Prostate Cancer before Chemotherapy
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Nov 2012
90 Presentations at Leading Radiation Oncology Meeting Demonstrate the Breadth and Depth of Clinical Evidence for Accuray Technologies
Devices Oncology
 HSMN NewsFeed - 5 Nov 2012
iCAD Reports Significantly Improved Medicare Payment for Intraoperative Radiation Therapy
Devices Oncology Reimbursement
 HSMN NewsFeed - 5 Nov 2012
Presentations at Leading Radiation Oncology Meeting Highlight CyberKnife Prostate Outcomes from Patients at More Than 40 Centers
Devices Oncology
 HSMN NewsFeed - 29 Oct 2012
Elekta’s Growth Through Innovation to Increase Use of Radiation Therapy and Improve Lives of Cancer Patients
Devices Oncology
 HSMN NewsFeed - 29 Oct 2012
IsoRay's Brain and Lung Cancer Products Showcased at the American Society for Radiation Oncology (ASTRO) Convention
Devices Oncology
 HSMN NewsFeed - 29 Oct 2012
iCAD Reports Growing Adoption of Its Xoft Electronic Brachytherapy System by Leading U.S. Regional Hospitals
Devices Oncology
 HSMN NewsFeed - 28 Oct 2012
Accuray Launches New TomoTherapy(R) H(TM) Series Featuring TomoEDGE(TM)
Devices Oncology
 HSMN NewsFeed - 24 Oct 2012
Theragenics Launches Galt Centeze(TM) Centesis Drainage Catheter Line of Products
Devices Surgery
 HSMN NewsFeed - 22 Oct 2012
FDA Approves New Non-Invasive, Non-Ionizing Radiation Therapy to Treat Pain from Bone Metastases
Devices Oncology FDA
 HSMN NewsFeed - 18 Oct 2012
A.P. Pharma Appoints Robert Rosen as Senior Vice President and Chief Commercial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 10 Oct 2012
Varian's 'GPS for the Body' Real-Time Tracking System Used for Prostate Patients at Leading U.K. Radiotherapy Clinic
Devices Oncology
 HSMN NewsFeed - 10 Oct 2012
Mitomics Announces U.S. Sales and Marketing Agreement with LabCorp
Diagnostics Urology
 HSMN NewsFeed - 9 Oct 2012
EDAP Appoints Experienced Lithotripsy Expert to Increase U.S. Sales
Devices Urology Personnel
 HSMN NewsFeed - 4 Oct 2012
Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 10 Sep 2012
U.K. Center Combines Elekta's Agility Beam-shaping Solution with Fast VMAT Delivery to Significantly Cut Cancer Patients' Radiotherapy Treatment Time
Devices Oncology
 HSMN NewsFeed - 29 Aug 2012
U.S. FDA Grants Priority Review of ZYTIGA(R) (abiraterone acetate) sNDA for Treatment of Metastatic Castration-Resistant Prostate Cancer Before Chemotherapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Aug 2012
Tokai Pharmaceuticals Appoints Adrian M. Senderowicz, M.D., as Chief Medical Officer and Vice President, Medical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2012
A.P. Pharma Appoints Robert Rosen to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2012
Debiopharm Group(TM) - First Patient Treated in Phase III Study With Subcutaneous Administration of Debio 8206 for Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Jul 2012
Accuray to Acquire Morphormics, Inc.
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 16 Jul 2012
Largest Public Hospital in Sydney Delivers First Treatment in Australia Using Advanced TrueBeam Radiotherapy and Radiosurgery Device
Devices Oncology
 HSMN NewsFeed - 26 Jun 2012
Spiracur Announces New SNaP Bridge Dressing for Plantar Surface Wound Care
Devices Wound Care
 HSMN NewsFeed - 12 Jun 2012
Tokai Pharmaceuticals’ Galeterone Receives Fast Track Designation from the FDA for the Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Jun 2012
CyberKnife(R) Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
Devices Oncology Urology
 HSMN NewsFeed - 5 Jun 2012
IsoRay Announces World's First Cesium-131 Mesh Treatment for Meningioma Brain Tumors
Devices Neurosurgery Oncology
 HSMN NewsFeed - 31 May 2012
EDAP Aligns Management Team to Maximize Global Opportunities
Devices Personnel
 HSMN NewsFeed - 22 May 2012
IsoRay’s GliaSite Approved for Sale in 31 European Countries
Devices Oncology Regulatory
 HSMN NewsFeed - 17 May 2012
Northwest Bio Provides Update On DCVax(R)-L Brain Cancer Trial
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 May 2012
IsoRay to Introduce GliaSite and Cesium-131 Mesh to International Audience at World Congress of Brachytherapy
Devices Oncology
 HSMN NewsFeed - 4 May 2012
Breastlink Medical Group to Offer iCAD’s Xoft Radiation Therapy System to Breast Cancer Patients
Devices Oncology
 HSMN NewsFeed - 3 May 2012
Pink Lotus Breast Center to Launch IORT Program Featuring iCAD’s Xoft Radiation Therapy System for Breast Cancer Patients
Devices Oncology
 HSMN NewsFeed - 26 Apr 2012
Jazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA Pharma
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 26 Apr 2012
Theragenics Receives FDA Clearance to Market Galt VTI(TM) Valved Tearaway Introducer
Devices FDA
 HSMN NewsFeed - 17 Apr 2012
Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer
Diagnostics Personalized Medicine Oncology Licensing
 HSMN NewsFeed - 17 Apr 2012
Statement by Dr. Eugen Hug, Chief Medical Officer of ProCure Treatment Centers, Regarding the University of North Carolina Study Comparing Proton Therapy and Intensity Modulated Radiation Therapy (IMRT) for Prostate Cancer
Devices Oncology
 HSMN NewsFeed - 12 Apr 2012
Thought Leaders in Radiation Medicine Convene to Discuss Safety and Advancements in Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 12 Apr 2012
EDAP Installs Ablatherm-HIFU at Dedicated HIFU Clinic in Poland
Devices Oncology
 HSMN NewsFeed - 5 Apr 2012
Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP(R) (aflibercept)
Biopharmaceuticals
 HSMN NewsFeed - 28 Mar 2012
Kapil Dhingra, Former Head of Roche Oncology, Joins Exosome Diagnostics Board of Directors
Diagnostics Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 8 Mar 2012
The Radiosurgery Society(TM) Completes its First Scientific Meeting as an Independent Society
Devices Oncology
 HSMN NewsFeed - 8 Mar 2012
Bellicum Closes $20 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Mar 2012
Aragon Pharmaceuticals Secures $42 Million in Series C Financing to Advance Pipeline of Therapies Targeting Hormone-Driven Cancers
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 1 Mar 2012
Australian Clinic Puts Prostate Cancer Radiation Therapy on Fast Track With Elekta VMAT and Integrity Digital Control System
Devices Oncology
 HSMN NewsFeed - 28 Feb 2012
FIRMAGON(R) (degarelix) demonstrates non-inferiority to goserelin with bicalutamide in reducing prostate volume in prostate cancer patients while providing better relief from lower urinary tract symptoms
Biopharmaceuticals Urology Oncology
 HSMN NewsFeed - 20 Feb 2012
Theragenics Acquires Core Oncology’s Prostate Brachytherapy Customer Base
Devices Oncology Acquisitions
 HSMN NewsFeed - 15 Feb 2012
FDA Approves Gen-Probe's PROGENSA(R) PCA3 Assay, First Urine-Based Molecular Test to Help Determine Need for Repeat Prostate Biopsies
Diagnostics FDA
 HSMN NewsFeed - 2 Feb 2012
EUSA Pharma Acquires Development and Commercialization Rights to ASPAREC(R) for Treatment of Acute Lymphoblastic Leukemia from Alizé Pharma
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 1 Feb 2012
Dendreon Announces CEO and Chairman Succession Plan
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jan 2012
EDAP Regains Ablatherm(R)-HIFU Distribution Rights in Canada and Caribbean
Devices Distribution
 HSMN NewsFeed - 6 Dec 2011
Varian Medical Systems Adds High Dose Delivery and Prone Breast Treatment Capabilities to Clinac(R) and Trilogy(R) Cancer Treatment Machines
Devices Oncology
 HSMN NewsFeed - 6 Dec 2011
Spectros Corporation Signs Distribution Agreements in Middle East
Devices Monitoring Distribution
 HSMN NewsFeed - 22 Nov 2011
IsoRay Receives Final Regulatory Approval for GliaSite(R) Brain Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 21 Nov 2011
Dendreon Announces the Centers for Medicare and Medicaid Services (CMS) Will Now Cover Infusion Costs Associated with the Administration of PROVENGE
Biopharmaceuticals Oncology Reimbursement
 HSMN NewsFeed - 18 Nov 2011
EUSA Pharma Announces FDA Approval of Orphan Drug ERWINAZE(TM) for Treatment of Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Nov 2011
EDAP Generates First U.S. Sonolith i-move Lithotripter Sale
Devices Urology
 HSMN NewsFeed - 3 Nov 2011
Viamet Pharmaceuticals Appoints Former Novartis Executive Marc Rudoltz, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Nov 2011
IsoRay Announces Major International Distribution Agreement for GliaSite(R)
Devices Oncology Distribution
 HSMN NewsFeed - 25 Oct 2011
Exelixis Appoints Executive Vice President and Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Oct 2011
Health Discovery Corporation Agrees with the U.S. Preventive Services Task Force’s Position Against PSA-Based Screening for Prostate Cancer and Believes Its Four-Gene Assay for Prostate Cancer is the Best Alternative to PSA
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 5 Oct 2011
Spectros T-Stat Shown to Be Earliest Available Method for Detection of Surgical Skin Flap Compromise After Surgery
Devices Surgery Monitoring
 HSMN NewsFeed - 20 Sep 2011
Tokai Pharmaceuticals Raises $23 Million in Funding
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 19 Sep 2011
Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 19 Sep 2011
FDA Approves New Indications for Prolia(R) (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Sep 2011
FDA Clears IsoRay's GliaSite(R) Treatment for Brain Cancer
Devices Oncology FDA
 HSMN NewsFeed - 30 Aug 2011
Accuray Drives Growth in Radiosurgery for Early-Stage Prostate Cancer
Devices Oncology
 HSMN NewsFeed - 30 Aug 2011
Progenics and Salix Announce FDA Acceptance of sNDA Filing for RELISTOR(R) in Patients with Non-Cancer Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Aug 2011
FDA Grants Fast Track Designation to Bayer's Investigational Compound Radium-223 Chloride for the Treatment of Castration-Resistant Prostate Cancer That Has Spread to the Bone
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Aug 2011
Al Kindy Hospital in Morocco Carries Out First RapidArc(R) Radiotherapy Treatments in North Africa
Devices Oncology
 HSMN NewsFeed - 2 Aug 2011
New NCCN Patient Guidelines Help Patients Navigate the Maze of Breast Cancer Treatment Options
Oncology
 HSMN NewsFeed - 1 Aug 2011
First Multi-Site Study Evaluates New Targeted Radiation Approach for Shortened, Safer Prostate Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 28 Jul 2011
Polaris Group Doses First Patient in Pivotal Phase 3 Clinical Trial of Lead Therapeutic Candidate ADI-PEG 20 for the Treatment of Hepatocellular Carcinoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Jul 2011
XGEVA(R) (Denosumab) Granted Marketing Authorization in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Jul 2011
ActiViews, Inc. Announces FDA 510(k) Clearance of CT-Guide™ Needle Guidance System for Lung Interventions
Devices Interventional FDA
 HSMN NewsFeed - 13 Jul 2011
Medivation Names Stewart Hallett Vice President of Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jul 2011
IsoRay Announces World's First Cesium-131 Treatment for Lung Cancer Using da Vinci Robotic Surgery System
Devices Oncology
 HSMN NewsFeed - 6 Jul 2011
Coronado Biosciences Closes $25.8M in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Jul 2011
Precision Biopsy Formally Closes a $2.5MM Round of Funding
Devices Oncology Venture Capital
 HSMN NewsFeed - 20 Jun 2011
Abbott Receives FDA Approval for a New Six-Month Formulation of Lupron Depot(R) (leuprolide acetate for depot suspension) for the Palliative Treatment of Advanced Prostate Cancer
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 13 Jun 2011
Spectros Corporation Introduces Continuum(R), a Broadband Infrared Sensor for Brain and Gut Oximetry
Devices Monitoring
 HSMN NewsFeed - 9 Jun 2011
Northwest Biotherapeutics Announces Change and Expansion of Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jun 2011
FDA Approves Trial of Adamis Pharmaceuticals Product Candidate to Treat Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Jun 2011
IsoRay Acquires Exclusive Worldwide License for Liquid Iodine Iotrex(R) for GliaSite(R) Brain Cancer Treatment
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 6 Jun 2011
ZALTRAP (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Jun 2011
Bayer's Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2011
Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2011
Amgen Receives CHMP Positive Opinion for XGEVA (Denosumab) in the European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 12 May 2011
Varian Medical Systems Makes Equity Investment and Obtains Option to Purchase Augmenix
Devices Oncology
 HSMN NewsFeed - 11 May 2011
Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Approaches at the American Urological Association Meeting in Washington, D.C.
Devices Oncology Urology
 HSMN NewsFeed - 28 Apr 2011
Results Promising From U.K. Clinical Trial Investigating Sonablate HIFU as a Focal Treatment for Prostate Cancer
Devices Oncology
 HSMN NewsFeed - 20 Apr 2011
Aduro BioTech Completes $19.25 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Apr 2011
University of Virginia Installs First Two TomoTherapy(R) TomoHD(TM) Systems in U.S.
Devices Oncology
 HSMN NewsFeed - 4 Apr 2011
superDimension Receives FDA 510(k) Clearance for Marker Delivery Kit
Devices FDA
 HSMN NewsFeed - 31 Mar 2011
Apthera and RXi Pharmaceuticals Announce Definitive Merger Agreement
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 31 Mar 2011
RXi Pharmaceuticals Aggressively Moves into Late-Stage Clinical Development with the Agreement to Acquire Apthera, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 21 Mar 2011
Kyphon(R) Balloon Kyphoplasty Found Beneficial for Treating Spinal Fractures in Cancer Patients
Devices Orthopaedic Neurosurgery Oncology
 HSMN NewsFeed - 10 Mar 2011
Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Mar 2011
Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX(R) Phase III Double-Blind Studies for Peyronie's Disease
Biopharmaceuticals
 HSMN NewsFeed - 2 Mar 2011
iCAD Features Image Analysis Solutions for Breast, Prostate and Colon Cancer Detection at the ECR 2011
Devices Radiology Oncology
 HSMN NewsFeed - 2 Mar 2011
GTx and Ipsen Terminate Their Toremifene Collaboration
Biopharmaceuticals
 HSMN NewsFeed - 1 Mar 2011
Paloma Pharmaceuticals Update on Ocular Clinical and Oncology Programs
Biopharmaceuticals Ophthalmology Oncology
 HSMN NewsFeed - 16 Feb 2011
Mitomics Further Strengthens Leadership Team
Diagnostics Oncology Personnel
 HSMN NewsFeed - 7 Feb 2011
Cancer Patients in Bangladesh Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 1 Feb 2011
Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jan 2011
Calypso Medical Names Edward Vertatschitsch President and Chief Executive Officer
Devices Oncology Personnel
 HSMN NewsFeed - 20 Jan 2011
EDAP Continues Its Growth Strategy; Enters New Major Market for Lithotripsy
Devices Urology
 HSMN NewsFeed - 19 Jan 2011
Andrew von Eschenbach, M.D., Former FDA Commissioner and Leading Prostate Cancer Expert, Elected to Viamet Pharmaceuticals Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jan 2011
James E. Shipley, M.D., Named Chief Medical Officer of Concert Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jan 2011
Eigen Completes Company Restructuring
Devices Urology Oncology
 HSMN NewsFeed - 18 Jan 2011
PrognosDx Announces Appointments of Dr. Garry Nolan to Board of Directors and Dr. Joseph Presti to Scientific Advisory Board
Diagnostics Oncology Personalized Medicine Personnel
 HSMN NewsFeed - 13 Jan 2011
Adamis Pharmaceuticals Announces Appointment of New Additional Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jan 2011
First Five-Year Outcomes Published on CyberKnife Radiosurgery for Prostate Cancer
Devices Oncology
 HSMN NewsFeed - 10 Jan 2011
Exelixis’ XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Jan 2011
Melanoma, Ovarian, and Prostate Cancer Treatment Guidelines for Patients Available from NCCN
Oncology
 HSMN NewsFeed - 16 Dec 2010
Calypso Medical and Elekta Corporation Enter into Master Development Agreement for Radiation Therapy Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 13 Dec 2010
XGEVA (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Dec 2010
Teva Announces Successful Results of Phase III Study with Oral Laquinimod for Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Dec 2010
Bavarian Nordic Receives Special Protocol Assessment Agreement From the FDA for Phase 3 Trial of PROSTVAC(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Nov 2010
OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Nov 2010
Calypso Medical Introduces Dynamic Edge(TM) Gating Technology at ASTRO
Devices Oncology
 HSMN NewsFeed - 29 Oct 2010
Accuray's CyberKnife VSI System Featured at 2010 American Society for Radiation Oncology (ASTRO) Annual Meeting
Devices Oncology
 HSMN NewsFeed - 29 Oct 2010
CyberKnife(R) VSI System Expands Treatment Applications and Significantly Reduces Treatment Times
Devices Oncology
 HSMN NewsFeed - 27 Oct 2010
Calypso Medical Initiates First Clinical Study Using Real-Time Tracking During Lung Cancer Radiotherapy
Devices Oncology
 HSMN NewsFeed - 27 Oct 2010
Successful IsoRay Study of Cesium-131 Internal Radiation Therapy for Breast Cancer Paves the Way for Advanced Treatment
Devices Oncology
 HSMN NewsFeed - 25 Oct 2010
BSD Medical Announces Purchase of BSD-500 Hyperthermia System by University Medical Center of Göttingen, Germany
Devices Oncology
 HSMN NewsFeed - 15 Oct 2010
Mayo Clinic Finds Early Success with Laser that Destroys Tumors with Heat
Devices Oncology Radiology
 HSMN NewsFeed - 13 Oct 2010
IsoRay's Revolutionary Internal Radiation Therapy for Lung Cancers is Focus of National Study
Devices Oncology
 HSMN NewsFeed - 12 Oct 2010
Spectrum Pharmaceuticals Announces Appointment of Brett L. Scott as Senior Vice President and Acting Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Oct 2010
Abiraterone Acetate Significantly Improved Overall Survival for Patients with Metastatic Advanced Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Oct 2010
Calypso Medical Receives FDA 510(k) Clearance for Dynamic Edge Gating Technology
Devices Oncology FDA
 HSMN NewsFeed - 7 Oct 2010
IsoRay Announces World's First Cesium-131 Treatment for Metastasized Lung Cancer
Devices Oncology
 HSMN NewsFeed - 6 Oct 2010
100,000th Patient Treated With Accuray's CyberKnife(R) Robotic Radiosurgery System
Devices Oncology Neurosurgery
 HSMN NewsFeed - 6 Oct 2010
New Data Demonstrate Treatment With STELARA(R) (Black Triangle Drug) (ustekinumab) Results in Sustained Improvements in Psoriasis Severity and Quality of Life up to Three Years
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 5 Oct 2010
NormOxys, Inc. Appoints Dr. Gerard Riedel as Vice President, Regulatory Affairs and Program Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2010
Phase III Data Showing Improved Survival With Jevtana(R) (cabazitaxel) Injection in Second-Line Advanced Prostate Cancer Published in The Lancet
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Sep 2010
InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010
Devices Surgery
 HSMN NewsFeed - 28 Sep 2010
Predictive Biosciences Appoints New Members to Leadership Team
Diagnostics Oncology Urology Personnel
 HSMN NewsFeed - 27 Sep 2010
Pfizer Discontinues Phase 3 Trial of SUTENT(R) in Advanced Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Sep 2010
Chronix Biomedical Announces Completion of Series E Financing
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 4 Aug 2010
iCAD Announces FDA Clearance of the Company's Computer-Aided Detection Product for Virtual Colonoscopy
Devices Radiology Gastroenterology FDA
 HSMN NewsFeed - 3 Aug 2010
GenSpera Acquires Rights to Cancer Imaging Technology to Create a New Generation of Medical Imaging Tools for Oncologists
Devices Radiology Oncology Acquisitions
 HSMN NewsFeed - 2 Aug 2010
Aragon Pharmaceuticals Appoints Richard A. Heyman CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Jul 2010
Richard B. Brewer Joins Nile Therapeutics as Executive Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2010
Endo Pharmaceuticals Completes Acquisition of HealthTronics, Inc.
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 12 Jul 2010
Theragenics Announces Supply and Reseller Agreement with Oncura
Devices Oncology Distribution
 HSMN NewsFeed - 2 Jul 2010
Breast Cancer Patient First in Latin America to Receive Treatment Using Elekta VMAT Planned with Monaco Software
Devices Oncology
 HSMN NewsFeed - 23 Jun 2010
IsoRay and Hologic Sign Exclusive Worldwide License for Crucial Brain Cancer Treatment Device
Devices Oncology Licensing
 HSMN NewsFeed - 16 Jun 2010
Predictive Biosciences Closes $25 Million Series C Financing
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 4 Jun 2010
Bayer Presents Clinical Data on Alpharadin in Metastatic Castration-Resistant Prostate Cancer (CRPC)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2010
Accuray Installs 200th CyberKnife Robotic Radiosurgery System
Devices Oncology
 HSMN NewsFeed - 1 Jun 2010
Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian
Devices Oncology
 HSMN NewsFeed - 28 May 2010
Misonix Announces Sale of Focus Surgery Related HIFU Business and Other HIFU Assets to USHIFU
Devices Acquisitions Distribution
 HSMN NewsFeed - 28 May 2010
US HIFU Acquires European Distribution Rights of the Sonablate(R) 500 Medical Device and Ownership of the Sonatherm(R) 600 Medical Device
Devices Acquisitions Distribution
 HSMN NewsFeed - 28 May 2010
Prolia(R) (Denosumab) Granted Marketing Authorization in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 May 2010
Calypso Medical's Real-Time Tumor Tracking Technology Improving Prostate Cancer Care
Devices Oncology
 HSMN NewsFeed - 26 May 2010
Predictive Biosciences Expands Leadership Team and Commercial Sales Force
Diagnostics Oncology Personnel
 HSMN NewsFeed - 19 May 2010
Allostera Pharma Inc. Appoints Christopher Henney as Chairman of its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 May 2010
John Theurer Cancer Center Offers Breakthrough Radiation Measurement Technology
Devices Oncology
 HSMN NewsFeed - 17 May 2010
Elekta / Mitsubishi Electric Collaboration Helps Japan's Gunma University Heavy Ion Medical Center Launch Advanced Carbon Ion Therapy for Treating Cancer
Devices Oncology
 HSMN NewsFeed - 6 May 2010
HealthTronics Enters Into Definitive Merger Agreement With Endo Pharmaceuticals
Devices Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 May 2010
ARIAD Announces Restructuring of Its Ridaforolimus Collaboration with Merck
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 29 Apr 2010
Bavarian Nordic Receives FDA Fast Track Designation for PROSTVAC(TM)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Apr 2010
Aragon Pharmaceuticals Secures $22 Million in Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 16 Apr 2010
University Hospital Zurich First in the World to Treat Cancer Patients with New TrueBeam(TM) System from Varian Medical Systems
Devices Oncology
Return to NewsFeed  

 Additional items found! 500

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 500 additional stories matching:
Prostate Cancer
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.